Chugai Pharmaceutical Co. Ltd.

06/22/2022 | Press release | Distributed by Public on 06/22/2022 01:05

Galderma Announces Topline Results of OLYMPIA 2 Study Evaluating Nemolizumab in Prurigo Nodularis